<div class="container">

<table style="width: 100%;"><tr>
<td>cgd</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>CGD Infection Data</h2>

<h3>Description</h3>

<p>The CGD data set presented by Fleming and Harrington (1991) and
Therneau and Lumley (2015) consists
of a placebo-controlled randomized trial of gamma interferon (rIFN-g)
in the treatment of chronic granulomatous disease (CGD). 128 patients
from 13 centers were tracked for around 1 year.
The number (i.e., cluster size) of patients per center ranged from 4 to
26. The survival times are the recurrent infection times
of each patient from the different centers. Censoring occurred at the
last observation for all patients, except one, who experienced a serious
infection on the data he left the study; in the CGD study about 63 per
cent of the data were censored. The recurrent infection times for a given
patient are likely to be correlated. However, each patient belongs to one
of the 13 centers; hence, the correlation may also be attributed to a
center effect.
</p>


<h3>Usage</h3>

<pre><code class="language-R">data("cgd")</code></pre>


<h3>Format</h3>

<p>A data frame with 203 observations on the following 16 variables.
</p>

<dl>
<dt><code>id</code></dt>
<dd>
<p>subjects identifier for 128 patients</p>
</dd>
<dt><code>center</code></dt>
<dd>
<p>enrolling center for 13 centers</p>
</dd>
<dt><code>random</code></dt>
<dd>
<p>date of randomization</p>
</dd>
<dt><code>treat</code></dt>
<dd>
<p>a factor with levels <code>placebo</code> and <code>rIFN-g</code> (gamma interferon)</p>
</dd>
<dt><code>sex</code></dt>
<dd>
<p>a factor with levels <code>male</code> and <code>female</code></p>
</dd>
<dt><code>age</code></dt>
<dd>
<p>age in years at study entry</p>
</dd>
<dt><code>height</code></dt>
<dd>
<p>height in cm at study entry</p>
</dd>
<dt><code>weight</code></dt>
<dd>
<p>weight in kg at study entry</p>
</dd>
<dt><code>inherit</code></dt>
<dd>
<p>a factor for pattern of inheritance with levels <code>X-linked</code> and <code>autosomal</code></p>
</dd>
<dt><code>steroids</code></dt>
<dd>
<p>use of steroids at study entry with 1 (=yes) and 0(=no) </p>
</dd>
<dt><code>propylac</code></dt>
<dd>
<p>use of prophylactic antibiotics at study entry</p>
</dd>
<dt><code>hos.cat</code></dt>
<dd>
<p>a factor for centers into 4 goups with levels <code>US:NIH</code>, <code>US:other</code>, <code>Europe:Amsterdam</code> and <code>Europe:other</code></p>
</dd>
<dt><code>tstart</code></dt>
<dd>
<p>start of each time interval</p>
</dd>
<dt><code>enum</code></dt>
<dd>
<p>observation number within subject</p>
</dd>
<dt><code>tstop</code></dt>
<dd>
<p>end of each time interval</p>
</dd>
<dt><code>status</code></dt>
<dd>
<p>status with 1 for infection and 0 for censoring</p>
</dd>
</dl>
<h3>References</h3>

<p>Fleming, T.R. and Harrington, D.P. (1991). Counting Processes and
Survival Analysis. John Wiley and Sons, New York.
</p>
<p>Therneau, T. and Lumley, T. (2015). survival: Survival Analysis. R
package version 2.38-3.
</p>


</div>